Kyeong Ho Yun
Overview
Explore the profile of Kyeong Ho Yun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Kwon W, Lee J, Yun K, Choi K, Lee S, Lee J, et al.
Circ Cardiovasc Interv
. 2023 Nov;
16(12):e013359.
PMID: 38018841
Background: The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated that intravascular imaging-guided percutaneous coronary intervention (PCI) improved clinical...
22.
Kim B, Lee S, Lee Y, Chan You S, Hong S, Yun K, et al.
Sci Rep
. 2023 Nov;
13(1):20157.
PMID: 37978309
We aimed to evaluate sex differences in the effects of moderate-intensity statin with ezetimibe combination therapy (rosuvastatin 10 mg plus ezetimibe) versus high-intensity statin (rosuvastatin 20 mg) monotherapy in patients...
23.
Lee J, Kim H, Lee J, Choi K, Song Y, Lee S, et al.
JACC Cardiovasc Imaging
. 2023 Nov;
17(3):336-338.
PMID: 37943231
No abstract available.
24.
Seung J, Choo E, Kim C, Kim H, Park K, Lee S, et al.
Circ Cardiovasc Interv
. 2023 Nov;
17(1):e013611.
PMID: 37929584
Background: The benefit of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) for noninfarct-related artery (IRA) lesions with angiographically severe stenosis in patients with acute myocardial infarction is unclear. Methods:...
25.
Hong S, Lee S, Suh Y, Yun K, Kang T, Shin S, et al.
Circulation
. 2023 Oct;
149(8):562-573.
PMID: 37878786
Background: Stopping aspirin within 1 month after implantation of a drug-eluting stent for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome. The aim of this...
26.
Hong D, Kim S, Lee S, Choi K, Song Y, Lee J, et al.
Circulation
. 2023 Sep;
148(11):903-905.
PMID: 37695832
No abstract available.
27.
Cho J, Joo D, Yun K, Kim B, Hong M, Jang Y, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1237826.
PMID: 37614943
Background: The aim of this study was to evaluate the efficacy and safety of ticagrelor monotherapy in patients with small vessel disease compared with ticagrelor-based DAPT within the Ticagrelor Monotherapy...
28.
Lee S, Jeong Y, Yun K, Cho J, Gorog D, Angiolillo D, et al.
JACC Cardiovasc Interv
. 2023 Aug;
16(15):1845-1855.
PMID: 37587591
Background: After a brief period of dual antiplatelet therapy, P2Y inhibitor monotherapy in the absence of aspirin effectively reduces bleeding without increasing recurrent ischemia in patients undergoing percutaneous coronary intervention...
29.
Won M, Yun K, Kim H, Son Y
Eur J Cardiovasc Nurs
. 2023 Aug;
23(3):287-295.
PMID: 37579073
Aims: We investigated the prevalence of sarcopenia and its influence on 1-year major adverse cardiac events (MACEs) in patients after successful percutaneous coronary intervention (PCI). Methods And Results: This retrospective...
30.
Doan K, Liu T, Yun W, Kim Y, Yun K, Oh S, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373765
Background: Calcified coronary lesions can cause stent under-expansion, malapposition, and polymer degradation, hence increasing the risk of adverse clinical outcomes. Percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS) has...